Clinical trial NCT03088345 - References

Congenital Heart Disease — Early Use of Vasopressin in Post-Fontan Management

Citation(s)

•   Alten JA, Borasino S, Toms R, Law MA, Moellinger A, Dabal RJ
  Early initiation of arginine vasopressin infusion in neonates after complex cardiac surgery. Pediatr Crit Care Med. 2012 May;13(3):300-4. doi: 10.1097/PCC.0b013e31822f1753.
•   Argenziano M, Choudhri AF, Oz MC, Rose EA, Smith CR, Landry DW
  A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation. 1997 Nov 4;96(9 Suppl):II-286-90.
•   Delmas A, Leone M, Rousseau S, Albanèse J, Martin C
  Clinical review: Vasopressin and terlipressin in septic shock patients. Crit Care. 2005 Apr;9(2):212-22. Epub 2004 Sep 9. Review.
•   Dünser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR
  The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg. 2001 Jul;93(1):7-13.
•   Evora PR, Pearson PJ, Schaff HV
  Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest. 1993 Apr;103(4):1241-5.
•   Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG, Charpie JR, Hirsch JC
  Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med. 2010 Mar;11(2):234-8. doi: 10.1097/PCC.0b013e3181b806fc.
•   Gaies MG, Jeffries HE, Niebler RA, Pasquali SK, Donohue JE, Yu S, Gall C, Rice TB, Thiagarajan RR
  Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries. Pediatr Crit Care Med. 2014 Jul;15(6):529-37. doi: 10.1097/PCC.0000000000000153.
•   Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD
  Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy. 2004 Aug;24(8):1002-12.
•   Hirsch JC, Goldberg C, Bove EL, Salehian S, Lee T, Ohye RG, Devaney EJ
  Fontan operation in the current era: a 15-year single institution experience. Ann Surg. 2008 Sep;248(3):402-10. doi: 10.1097/SLA.0b013e3181858286.
•   Jerath N, Frndova H, McCrindle BW, Gurofsky R, Humpl T
  Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients. Intensive Care Med. 2008 Jul;34(7):1274-80. doi: 10.1007/s00134-008-1055-2. Epub 2008 Mar 19.
•   Kampmeier TG, Rehberg S, Westphal M, Lange M
  Vasopressin in sepsis and septic shock. Minerva Anestesiol. 2010 Oct;76(10):844-50. Review.
•   Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA
  Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997 Mar 4;95(5):1122-5.
•   Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA
  Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997 Aug;25(8):1279-82.
•   Lechner E, Hofer A, Mair R, Moosbauer W, Sames-Dolzer E, Tulzer G
  Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass. Eur J Pediatr. 2007 Dec;166(12):1221-7. Epub 2007 Jan 16.
•   Leibovitch L, Efrati O, Vardi A, Matok I, Barzilay Z, Paret G
  Intractable hypotension in septic shock: successful treatment with vasopressin in an infant. Isr Med Assoc J. 2003 Aug;5(8):596-8.
•   Mastropietro CW, Clark JA, Delius RE, Walters HL 3rd, Sarnaik AP
  Arginine vasopressin to manage hypoxemic infants after stage I palliation of single ventricle lesions. Pediatr Crit Care Med. 2008 Sep;9(5):506-10. doi: 10.1097/PCC.0b013e3181849ce0.
•   Mastropietro CW, Rossi NF, Clark JA, Chen H, Walters H 3rd, Delius R, Lieh-Lai M, Sarnaik AP
  Relative deficiency of arginine vasopressin in children after cardiopulmonary bypass. Crit Care Med. 2010 Oct;38(10):2052-8. doi: 10.1097/CCM.0b013e3181eed91d.
•   Meyer DB, Zamora G, Wernovsky G, Ittenbach RF, Gallagher PR, Tabbutt S, Gruber PJ, Nicolson SC, Gaynor JW, Spray TL
  Outcomes of the Fontan procedure using cardiopulmonary bypass with aortic cross-clamping. Ann Thorac Surg. 2006 Nov;82(5):1611-8; discussion 1618-20.
•   Morrison WE, Simone S, Conway D, Tumulty J, Johnson C, Cardarelli M
  Levels of vasopressin in children undergoing cardiopulmonary bypass. Cardiol Young. 2008 Apr;18(2):135-40. doi: 10.1017/S1047951108001881. Epub 2008 Mar 7.
•   Novella S, Martínez AC, Pagán RM, Hernández M, García-Sacristán A, González-Pinto A, González-Santos JM, Benedito S
  Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 2007 Jul;32(1):69-76. Epub 2007 May 15.
•   Rosenzweig EB, Starc TJ, Chen JM, Cullinane S, Timchak DM, Gersony WM, Landry DW, Galantowicz ME
  Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation. 1999 Nov 9;100(19 Suppl):II182-6.
•   Sai Y, Okamura T, Amakata Y, Toda N
  Comparison of responses of canine pulmonary artery and vein to angiotensin II, bradykinin and vasopressin. Eur J Pharmacol. 1995 Aug 25;282(1-3):235-41.
•   Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA 3rd
  Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001 Mar;29(3):487-93.
•   Tweddell JS, Nersesian M, Mussatto KA, Nugent M, Simpson P, Mitchell ME, Ghanayem NS, Pelech AN, Marla R, Hoffman GM
  Fontan palliation in the modern era: factors impacting mortality and morbidity. Ann Thorac Surg. 2009 Oct;88(4):1291-9. doi: 10.1016/j.athoracsur.2009.05.076.

Use of Arginine Vasopressin in Early Postoperative Management After Fontan Palliation

Details for clinical trial NCT03088345